Shares of Option Care Health OPCH remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share increased 550.00% year over year to $0.18, which beat the estimate of $0.09.
Revenue of $860,272,000 up by 16.12% from the same period last year, which beat the estimate of $784,190,000.
Guidance
Option Care Health sees FY21 sales of $3.35 billion-$3.50 billion.
Conference Call Details
Date: Aug 03, 2021
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/r2us3rcf
Technicals
Company's 52-week high was at $22.69
Company's 52-week low was at $10.52
Price action over last quarter: Up 15.87%
Company Description
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.